Literature DB >> 30357068

Osteonecrosis of the Femoral Head: Etiology, Investigations, and Management.

Shakoor A Baig1, M N Baig2.   

Abstract

Femoral head osteonecrosis is a condition caused by a compromise of the blood supply of the femoral head. The precarious blood supply of the head and its role as a major weight-bearing joint makes it one of the most common bones to be affected by osteonecrosis. We describe the etiology, clinical presentation, investigations and common management options used nowadays to treat it.

Entities:  

Keywords:  bisphosphonates; core decompression; hyperbaric oxygen; osteonecrosis

Year:  2018        PMID: 30357068      PMCID: PMC6197539          DOI: 10.7759/cureus.3171

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction and background

Osteonecrosis (ON) or avascular necrosis of the femoral head is a condition characterized by the death of osteocytes and bone marrow. Osteonecrosis is caused by an inadequate blood supply to the affected segment of the subchondral bone and is sometimes called “coronary disease of the hip” because it simulates the ischemic condition of the heart.

Review

Osteonecrosis of the femoral head (ONFH) usually affects young adults in the third and fourth decades of life. There has been an increasing trend in its diagnosis; every year about 10,000 to 20,000 new cases are diagnosed in the United States [1]. According to the literature, about 5%-12% of hip arthroplasties are performed for the treatment of this condition per annum [2]. It starts with one femoral head being affected first; bilateral involvement occurs in two years in 72% of cases [2]. Etiology and pathophysiology There are two groups of patients diagnosed with hip osteonecrosis: (a) patients with no apparent etiological or risk factor and (b) patients with clearly identified etiology. Based on the etiology, osteonecrosis can be idiopathic (primary) or secondary. There are multiple contributory etiological factors of osteonecrosis. The use of glucocorticoids and excessive alcohol intake is associated with more than 80% of atraumatic cases. ONFH is the result of the combined effects of genetic predisposition, metabolic factors, and local factors affecting blood supply (e.g., vascular damage, increased intraosseous pressure, and mechanical stresses) [3-4]. The vascular anatomy varies, but a majority of the population has a lateral femoral circumflex artery, which gives rise to three or four branches (i.e., the retinacular vessels); an obturator artery that gives rise to the vessels within the ligamentum teres; and an ascending branch of the medial femoral circumflex artery, which supplies the greater trochanter and anastomoses with the lateral femoral circumflex artery (Figure 1) [5].
Figure 1

Femoral head blood supply

Femoral head and neck blood supply 

(Courtesy ALPF Medical Research)

Femoral head blood supply

Femoral head and neck blood supply (Courtesy ALPF Medical Research) In cases of trauma, the resulting osteonecrosis is better understood because the vascularity around the femoral head is severely disturbed as a result of the injury. The most common traumatic causes of OFNH are dislocations and fractures. About 15%-50% of displaced femoral neck fractures and 10%-25% of hip dislocations end in ONFH [6]. In the cases of ONFH cited in the literature, elevated intraosseous pressure has been measured secondary to venous outflow obstruction and venous stasis. In the studies measuring intraosseous pressure, the bone is considered a closed compartment and pressure increases due to the compromised blood supply in many conditions that are known to causes OFNH. Clinical presentation ONFH may be asymptomatic in the early stages. Clinically, the most common symptom is a deep pain in the groin. Pain may be referred to the ipsilateral buttock or knee. Symptoms worsen with weight bearing and are relieved with rest. The range of motion becomes limited, particularly hip abduction and internal rotation; logrolling (i.e., passive internal and external rotation) elicits pain [6]. Imaging The imaging modalities that help in the diagnosis of OFNH are plain anteroposterior and lateral “frog-leg” radiographs, computed tomography (CT) scans, and magnetic resonance imaging (MRI). Plain radiographs are the first imaging investigation given their low cost, simplicity, and availability. The disadvantage of radiographs is their insensitivity for detecting ON in its early stages. On X-rays, subchondral fracture (“crescent sign”) is one of the characteristic features usually present in the later stages of the disease (Figure 2). Advanced stages usually manifest as a degenerative joint disease (Figure 3) [7].
Figure 2

X-ray hip

Crescent sign. Arrows showing the hypointense crescent.

(Courtesy http://onradiology.blogspot.com)

Figure 3

X-ray right hip

Advanced osteonecrosis shown in the circle.

X-ray hip

Crescent sign. Arrows showing the hypointense crescent. (Courtesy http://onradiology.blogspot.com)

X-ray right hip

Advanced osteonecrosis shown in the circle. CT is considered the most sensitive test for detecting subchondral fracture of the femoral head. While radiographs and MRIs are useful, a CT delineates the outline of the subchondral bone (Figure 4) [7].
Figure 4

CT pelvis - coronal view

Osteonecrosis left hip encircled.

CT pelvis - coronal view

Osteonecrosis left hip encircled. MRI is the imaging investigation of choice with the highest sensitivity (99%) and specificity (99%) as compared to plain radiographs, CT, or scintigraphy. MRI is the most useful screening tool for early diagnosis and a quantitative evaluation of the disease extent within the femoral head; it is very helpful in the staging of the disease. A single-density “band-like” lesion is seen on T1-weighted images, which is based on a signal from ischemic marrow (Figure 5). There is a “double-line” sign on T2-weighted images representing hypervascular granulation tissue [8].
Figure 5

MRI left hip T1

T1 MRI image encircled, showing osteonecrosis in the femoral headband-like lesion.

MRI: Magnetic resonance imaging

MRI left hip T1

T1 MRI image encircled, showing osteonecrosis in the femoral headband-like lesion. MRI: Magnetic resonance imaging Classification In the literature, there are several classification systems used to determine the ON stage for prognosis and assist with treatment decisions. The two most common classifications used in the diagnosis of ONFH are the Ficat and Arlet classification and the Steinberg (University of Pennsylvania) classification [9]. There are three important factors for prognosis: the extent of the osteonecrosis lesion, the location of the lesion within the femoral head, and the presence of bone marrow edema in the proximal femur. Treatment Nonsurgical management starts with observation or protected weight bearing. It has a very limited role in the treatment of ONFH except for the follow-up of small asymptomatic lesions until they become symptomatic. Biophysical modalities have been used as well with limited success, such as extracorporeal shock waves and pulsed electromagnetic fields, but information on their use is sparse. Enoxaparin may prevent the progression of primary hip ON in patients with thrombophilia or hypofibrinolytic disorders [10]. Alendronate (bisphosphonate) to treat early-stage osteonecrosis was evaluated in two randomized trials, with conflicting results. The theory was the activity of osteoclasts could be inhibited to prevent or delay the collapse of the femoral head [11]. Hyperbaric oxygen therapy is a suggested joint-preserving treatment for symptomatic early-stage ONFH but is especially beneficial in Stage 1 and Stage 2 [12]. The surgical treatment of osteonecrosis can be broadly divided into femoral head-preserving procedures and hip arthroplasty. Femoral head-preserving procedures include core decompression with or without non-vascularised bone grafting, vascularised bone grafting, biologic adjuncts, tantalum rods, and rotational osteotomies. Core decompression has been widely used to treat early-stage ON and is intended to reduce intraosseous pressure in the femoral head, restore vascular flow, and improve pain. The procedure can be performed with a single core tract of varying size or with multiple small core tracts (Figure 6) [13-14].
Figure 6

ONFH and decompression

MRI with ONFH (left-sided image; star showing the osteonecrosis);

X-ray left hip; arrow showing osteonecrosis and decompression.

MRI: Magnetic resonance imaging; ONFH: Osteonecrosis of the femoral head

ONFH and decompression

MRI with ONFH (left-sided image; star showing the osteonecrosis); X-ray left hip; arrow showing osteonecrosis and decompression. MRI: Magnetic resonance imaging; ONFH: Osteonecrosis of the femoral head Core decompression can be supplemented with the insertion of allografts and non-vascularised autografts to provide mechanical support of the osteonecrotic lesion and prevent collapse. Grafting can be performed with the Phemister technique (through the core tract), light bulb technique (through a cortical window at the junction of the cartilage and the femoral neck), or the trap door technique (through a cartilage window) [15]. For vascularized bone grafting, the fibula or iliac crest graft supports the subchondral bone with a viable, strong bone strut and enhances the revascularization of the femoral head. Free vascularized bone grafting is technically demanding, requires expertise in microsurgery, and is associated with donor site morbidity (Figures 7-8) [16].
Figure 7

Illustration showing decompression and grafting

Post-decompression bone strut using a vascular fibular graft (shown in the circle).

(Courtesy: Penn Medicine)

Figure 8

Post-op grafting X-ray

X-ray showing bone grafting after decompression with the help of k-wires (Kirschner wires).

Illustration showing decompression and grafting

Post-decompression bone strut using a vascular fibular graft (shown in the circle). (Courtesy: Penn Medicine)

Post-op grafting X-ray

X-ray showing bone grafting after decompression with the help of k-wires (Kirschner wires). A tantalum implant has been used as an alternative to bone grafting following core decompression. The tantalum implant should provide mechanical and structural support to the necrotic area, enhanced bone ingrowth given its highly porous nature and osteoconductive micro-texture (Figures 9-10) [17-18].
Figure 9

Tantalum rod

Tantalum rod in vitro.

Figure 10

X-ray left hip with Tantalum rod

Tantalum rod in vivo highlighted by an arrow.

Tantalum rod

Tantalum rod in vitro.

X-ray left hip with Tantalum rod

Tantalum rod in vivo highlighted by an arrow. Osteotomies are another modality for treatment, with a goal to prevent femoral head collapse by transposing the osteonecrotic area from a weight-bearing to a non-weight-bearing area of the hip joint, thereby diverting mechanical stress from the lesion to healthy bone. Two types of osteotomies have been used: trans-trochanteric rotational osteotomies (anterior or posterior) and intertrochanteric varus or valgus osteotomies. The trans-trochanteric technique is popular in Japan, and its efficacy depends on the size of the osteonecrotic lesion. Trans-trochanteric osteotomies require a sufficiently large area of healthy bone and are technically demanding; the conversion of failed cases to total hip arthroplasty (THA) may be difficult (Figure 11) [19-20].
Figure 11

Illustration showing rotation osteotomy

The osteotomy is to rotate the damaged weight-bearing surface, so the undamaged area becomes the weight-bearing part of the femoral head.

(Courtesy: Nakashima Y, Kubota H, Yamamoto T, Mawatari T, Motomura G, Iwamoto Y: Transtrochanteric rotational osteotomy for late-onset Legg-Calve-Perthes disease. J Pediatr Orthop. 2011, 31:223-228)

Illustration showing rotation osteotomy

The osteotomy is to rotate the damaged weight-bearing surface, so the undamaged area becomes the weight-bearing part of the femoral head. (Courtesy: Nakashima Y, Kubota H, Yamamoto T, Mawatari T, Motomura G, Iwamoto Y: Transtrochanteric rotational osteotomy for late-onset Legg-Calve-Perthes disease. J Pediatr Orthop. 2011, 31:223-228) Total hip replacement is the surgical treatment that most reliably achieves pain relief and provides prompt functional return with a single procedure [21-22]. Patients with ON had a significantly higher dislocation rate than did patients with osteoarthritis because ON patients usually have a better preoperative range of motion compared with a patient with long-standing osteoarthritis. The revision rate in patients younger than age 50 with osteonecrosis was significantly higher compared with that in patients in the same age group with osteoarthritis [23-24]. When preparing an acetabulum in an osteonecrosis hip, the surgeon must remember that the bone quality may be poor secondary to corticosteroid use, lack of weight bearing, or the underlying disease. Resurfacing arthroplasty preserves bone and does not compromise subsequent conversion to THA. THA may be a viable option in the management of post-collapse ON in young patients with good bone stock [25].

Conclusions

Patients with symptomatic ON with small lesions should be treated with head-sparing procedures. Patients with large lesions in pre-collapse hips should be treated with head-sparing procedures if the patients are young or have THA in older patients. For patients with a collapsed femoral head, THA is the recommended option.
  25 in total

Review 1.  Classification systems for osteonecrosis: an overview.

Authors:  Marvin E Steinberg; David R Steinberg
Journal:  Orthop Clin North Am       Date:  2004-07       Impact factor: 2.472

2.  Transtrochanteric rotational osteotomy for late-onset Legg-Calve-Perthes disease.

Authors:  Yasuharu Nakashima; Hideaki Kubota; Takuaki Yamamoto; Taro Mawatari; Goro Motomura; Yukihide Iwamoto
Journal:  J Pediatr Orthop       Date:  2011-09       Impact factor: 2.324

3.  Osteonecrosis of the femoral head: diagnosis and classification systems.

Authors:  Ho-Rim Choi; Marvin E Steinberg; Edward Y Cheng
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

4.  A current review of core decompression in the treatment of osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Julio J Jauregui; Randa K Elmallah; Carlos J Lavernia; Michael A Mont; James Nace
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

5.  Enoxaparin prevents progression of stages I and II osteonecrosis of the hip.

Authors:  Charles J Glueck; Richard A Freiberg; Luann Sieve; Ping Wang
Journal:  Clin Orthop Relat Res       Date:  2005-06       Impact factor: 4.176

6.  [Avascular necrosis of the hip - diagnosis and treatment].

Authors:  W Drescher; T Pufe; R Smeets; R V Eisenhart-Rothe; M Jäger; M Tingart
Journal:  Z Orthop Unfall       Date:  2011-04-05       Impact factor: 0.923

7.  Hyperbaric oxygen for stage I and II femoral head osteonecrosis.

Authors:  Lior Koren; Eyal Ginesin; Yehuda Melamed; Doron Norman; Daniel Levin; Eli Peled
Journal:  Orthopedics       Date:  2015-03       Impact factor: 1.390

8.  Osteonecrosis of the femoral head: using CT, MRI and gross specimen to characterize the location, shape and size of the lesion.

Authors:  L B Hu; Z G Huang; H Y Wei; W Wang; A Ren; Y Y Xu
Journal:  Br J Radiol       Date:  2014-12-11       Impact factor: 3.039

9.  Tantalum rod implantation for femoral head osteonecrosis: survivorship analysis and determination of prognostic factors for total hip arthroplasty.

Authors:  Yaosheng Liu; Liang Yan; Shiguo Zhou; Xiuyun Su; Yuncen Cao; Cheng Wang; Shubin Liu
Journal:  Int Orthop       Date:  2015-08-11       Impact factor: 3.075

10.  Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years.

Authors:  Sokratis E Varitimidis; Apostolos P Dimitroulias; Theophilos S Karachalios; Zoe H Dailiana; Konstantinos N Malizos
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more
  17 in total

1.  Core decompression and bone marrow aspirate concentrate injection for Avascular Necrosis (AVN) of the femoral head: A scoping review.

Authors:  Nishant Pawar; Abhishek Vaish; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2021-11-11

2.  Neohesperidin promotes the osteogenic differentiation of human bone marrow stromal cells by inhibiting the histone modifications of lncRNA SNHG1.

Authors:  Chuanxin Zhang; Shuai Yuan; Yi Chen; Bo Wang
Journal:  Cell Cycle       Date:  2021-08-30       Impact factor: 5.173

3.  Applying deep learning to quantify empty lacunae in histologic sections of osteonecrosis of the femoral head.

Authors:  Elaine Lui; Masahiro Maruyama; Roberto A Guzman; Seyedsina Moeinzadeh; Chi-Chun Pan; Alexa K Pius; Madison S V Quig; Laurel E Wong; Stuart B Goodman; Yunzhi P Yang
Journal:  J Orthop Res       Date:  2021-10-27       Impact factor: 3.102

4.  Autologous bone marrow derived mesenchymal stem cell therapy for osteonecrosis of femoral head: A systematic overview of overlapping meta-analyses.

Authors:  Madhan Jeyaraman; Sathish Muthu; Rashmi Jain; Manish Khanna
Journal:  J Clin Orthop Trauma       Date:  2020-11-26

5.  Prediction of the progression of femoral head collapse in ARCO stage 2-3A osteonecrosis based on the initial bone resorption lesion.

Authors:  Shan Shi; Ping Luo; Li Sun; Limin Xie; Tong Yu; Zhenchang Wang; Xuedong Yang
Journal:  Br J Radiol       Date:  2020-11-12       Impact factor: 3.039

6.  Three-dimensional distribution of cystic lesions in osteonecrosis of the femoral head.

Authors:  Guang-Bo Liu; Rui Li; Qiang Lu; Hai-Yang Ma; Yu-Xuan Zhang; Qi Quan; Xue-Zhen Liang; Jiang Peng; Shi-Bi Lu
Journal:  J Orthop Translat       Date:  2019-11-14       Impact factor: 5.191

7.  Osteonecrosis of the hip: is there a difference in the survivorship of total hip arthroplasty with or without previous vascular iliac bone grafting?

Authors:  Wai-Wang Chau; Jonathan Patrick Ng; Hiu-Woo Lau; Michael Tim-Yun Ong; Kwong-Yin Chung; Kevin Ki-Wai Ho
Journal:  J Orthop Surg Res       Date:  2021-04-08       Impact factor: 2.359

8.  IKKe in osteoclast inhibits the progression of methylprednisolone-induced osteonecrosis.

Authors:  Yingjie Liu; Haojie Shan; Yang Zong; Yiwei Lin; Wenyang Xia; Nan Wang; Lihui Zhou; Youshui Gao; Xin Ma; Chaolai Jiang; Xiaowei Yu
Journal:  Int J Biol Sci       Date:  2021-03-30       Impact factor: 6.580

9.  Neohesperidin Ameliorates Steroid-Induced Osteonecrosis of the Femoral Head by Inhibiting the Histone Modification of lncRNA HOTAIR.

Authors:  Shuai Yuan; Chuanxin Zhang; Yunli Zhu; Bo Wang
Journal:  Drug Des Devel Ther       Date:  2020-12-07       Impact factor: 4.162

Review 10.  Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications.

Authors:  Elena Rezus; Bogdan Ionel Tamba; Minerva Codruta Badescu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.